Clinical trial

Use of Saliva for Alzheimer's Disease Diagnosis

NCT02864303

Study summary

ClinicalTrials.gov

Use of Saliva for Alzheimer's Disease Diagnosis

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Saliva samples Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-06-21

PhaseNA

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Mild Cognitive Impairmentunresolved

Interventions

Saliva samplesOTHER

Sponsors & collaborators

University Hospital, Montpellierlead sponsor

Mapped research locations

MontpellierFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02864303 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.